Infiniti 2C9 & Vkorc1 Multiplex Assay for Warfarin
Cytochrome P450 2c9 (Cyp450 2c9) Drug Metabolizing Enzyme Genotyping System. 510(k) K073014, from Autogenomics, Incorporated (Carlsbad, CA). Product code ODW, class 2.
As of Nov 20, 2026, K073014 is an FDA 510(k) held by Autogenomics, Incorporated, substantially equivalent on Jan 23, 2008 after 90 days, with no recalls tied to it in FDA's recall database.
- Review time: 90 days
- Recalls: 0
- Cited as a predicate by: 1 device
The INFINITI 2C9 & VKORC1 Multiplex Assay for Warfarin is an in vitro diagnostic test for the detection and genotyping of the *2 and *3 CYP4502C9 genetic variants and the VKORC1 3673 (-1639) intronic variant in genomic deoxyribonucleic acid (DNA) obtained from EDTA-anticoagulated whole blood samples.
- Roche Amplichip CYP450 TestK043576 · Roche Molecular Systems, Inc. · Jan 10, 2005
- Infiniti SystemK060564 · AutoGenomics, Inc. · Feb 7, 2007
- Infiniti CYP2C19 AssayK101683 · Autogenomics, Incorporated · Oct 25, 2010
- Document
- 510(k) summary (PDF) ↗
- Type
- Abbreviated
- Received
- Oct 25, 2007
- Review panel
- Clinical Toxicology
- Regulation
- 21 CFR 862.3360
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files